Aims: Uncontrolled asthma during pregnancy can lead to complications for both the mother and the fetus. In this study; It was aimed to evaluate the follow-up and treatment of pregnant women with asthma, their knowledge about asthma triggers, their use of inhaler therapy, and their compliance with pulmonologist controls for asthma.
Methods: In this study; 64 pregnant patients with asthma who applied to our clinic between 01.01.2022 and 31.07.2022 were reviewed. Demographic patients (mean age, age groups, smoking history, comorbidities), recommended treatment information, and birth information, whether they used asthma treatment or not, were recorded and evaluated according to patient groups.
Results: There was a statistically significant difference between drug use during pregnancy according to the age groups of pregnant women with asthma (Chi-square test; χ²=6.684; p=0.035). As the age of the pregnant women increased, the rate of drug use during the pregnancy increased, and there was a correlation between drug use during pregnancy and whether the patients were regularly checked by a pulmonologist (Chi-square test; χ²=12.835; p=0.0001). While 68% of those who were not under the control of a pulmonologist did not use medication, 60.8% of those under the control of a pulmonologist used medication during their pregnancy.
Conclusion: Pregnant women with asthma must be followed by a gynecologist and a pulmonologist. Using inhaler therapy in asthma treatment in pregnant women can keep asthma under control and reduce the number and severity of exacerbations.
Ethical Declaration All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Ethics committee approval has been granted from our institution. As this was a retrospective research no informed consent has been obtained from participants.
There is no specific funding related to this research.
Birincil Dil | İngilizce |
---|---|
Konular | Solunum Hastalıkları |
Bölüm | Research Articles |
Yazarlar | |
Yayımlanma Tarihi | 15 Ocak 2024 |
Yayımlandığı Sayı | Yıl 2024 Cilt: 6 Sayı: 1 |
Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]
- Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.
Not: Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamaktadır.
Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/3449/page/10809/update
Dergi Dizin ve Platformları
TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.